Applicant, as named in the Orange Book

Melinta Therap

Next listed expiry: Kimyrsa on 16 Jul 2035. 2 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Kimyrsa NDA 214155 oritavancin diphosphate	oritavancin diphosphate	16 Jul 2035 patent	patent
Orbactiv NDA 206334 oritavancin diphosphate	oritavancin diphosphate	16 Jul 2035 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Toprol-Xl NDA 019962 · 4 strengths metoprolol succinate	metoprolol succinate	open now no listed protection	no listed protection